Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bolhuis, R., Gratama, J. Genetic re-targeting of T lymphocyte specifity. Gene Ther 5, 1153–1155 (1998). https://doi.org/10.1038/sj.gt.3300697
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300697
This article is cited by
-
A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes
Cancer Immunology, Immunotherapy (2006)
-
Tumor antigen–specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor–modified T cells
Nature Biotechnology (2002)
-
A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes
Gene Therapy (2001)
-
Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production
Gene Therapy (2000)
-
Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR
Gene Therapy (2000)